Effect of ketoconazole on cholesterol synthesis and on HMG-COA reductase and LDL-receptor activities in Hep G2 cells
- 15 April 1987
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 36 (8), 1245-1249
- https://doi.org/10.1016/0006-2952(87)90077-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase.JCI Insight, 1986
- Effects of long-term ketoconazole therapy on serum lipid levelsEuropean Journal of Clinical Pharmacology, 1985
- KETOCONAZOLE AND CHOLESTEROL SYNTHESISThe Lancet, 1984
- Molecular basis for the antimycotic and antibacterial activity of N‐substituted imidazoles and triazoles: The inhibition of isoprenoid biosynthesisPesticide Science, 1984
- Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*Journal of Clinical Endocrinology & Metabolism, 1983
- Mode of insertion of miconazole, ketoconazole and deacylated ketoconazole in lipid layersBiochemical Pharmacology, 1983
- Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.JCI Insight, 1983
- THE EFFECT OF KETOCONAZOLE ON STEROIDOGENESIS IN CULTURED MOUSE ADRENAL CORTEX TUMOR CELLS*Endocrinology, 1983
- The interaction of miconazole and ketoconazole with lipidsBiochemical Pharmacology, 1982
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977